Optimizing Vaccine Trials for Enteric Diseases: The Enterics for Global Health (EFGH) Shigella Surveillance Study

Kirsten Vannice; Calman Alexander MacLennan; Jessica Long; Andrew Duncan Steele

doi:10.1093/ofid/ofad586

Optimizing Vaccine Trials for Enteric Diseases: The Enterics for Global Health (EFGH) Shigella Surveillance Study

Kirsten Vannice^*, Calman Alexander MacLennan, Jessica Long, Andrew Duncan Steele

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

In this introductory article, we describe the rationale for the Enterics for Global Health (EFGH) Shigella surveillance study, which is largely to optimize the design and implementation of pivotal Shigella vaccine trials in the target population of infants and young children living in low- and middle-income countries. Such optimization will ideally lead to a shorter time to vaccine availability in the target population. We also provide a brief description of the articles included in the supplement.

Original language	English
Pages (from-to)	S1-S5
Journal	Open Forum Infectious Diseases
Volume	11
Issue number	Supplement_1
DOIs	https://doi.org/10.1093/ofid/ofad586
Publication status	Published - 1 Mar 2024
Externally published	Yes

Keywords

Shigella
capacity building
children
low- and middle-income countries
vaccine

Access to Document

10.1093/ofid/ofad586

Cite this

@article{8caa80759d7341fb900ff8086c3c7f3b,

title = "Optimizing Vaccine Trials for Enteric Diseases: The Enterics for Global Health (EFGH) Shigella Surveillance Study",

abstract = "In this introductory article, we describe the rationale for the Enterics for Global Health (EFGH) Shigella surveillance study, which is largely to optimize the design and implementation of pivotal Shigella vaccine trials in the target population of infants and young children living in low- and middle-income countries. Such optimization will ideally lead to a shorter time to vaccine availability in the target population. We also provide a brief description of the articles included in the supplement.",

keywords = "Shigella, capacity building, children, low- and middle-income countries, vaccine",

author = "Kirsten Vannice and MacLennan, {Calman Alexander} and Jessica Long and Steele, {Andrew Duncan}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.",

year = "2024",

month = mar,

day = "1",

doi = "10.1093/ofid/ofad586",

language = "English",

volume = "11",

pages = "S1--S5",

journal = "Open Forum Infectious Diseases",

issn = "2328-8957",

publisher = "Oxford University Press",

number = "Supplement_1",

}

TY - JOUR

T1 - Optimizing Vaccine Trials for Enteric Diseases

T2 - The Enterics for Global Health (EFGH) Shigella Surveillance Study

AU - Vannice, Kirsten

AU - MacLennan, Calman Alexander

AU - Long, Jessica

AU - Steele, Andrew Duncan

N1 - Publisher Copyright: © The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

PY - 2024/3/1

Y1 - 2024/3/1

N2 - In this introductory article, we describe the rationale for the Enterics for Global Health (EFGH) Shigella surveillance study, which is largely to optimize the design and implementation of pivotal Shigella vaccine trials in the target population of infants and young children living in low- and middle-income countries. Such optimization will ideally lead to a shorter time to vaccine availability in the target population. We also provide a brief description of the articles included in the supplement.

AB - In this introductory article, we describe the rationale for the Enterics for Global Health (EFGH) Shigella surveillance study, which is largely to optimize the design and implementation of pivotal Shigella vaccine trials in the target population of infants and young children living in low- and middle-income countries. Such optimization will ideally lead to a shorter time to vaccine availability in the target population. We also provide a brief description of the articles included in the supplement.

KW - Shigella

KW - capacity building

KW - children

KW - low- and middle-income countries

KW - vaccine

UR - http://www.scopus.com/inward/record.url?scp=85188801659&partnerID=8YFLogxK

U2 - 10.1093/ofid/ofad586

DO - 10.1093/ofid/ofad586

M3 - Article

C2 - 38532964

AN - SCOPUS:85188801659

SN - 2328-8957

VL - 11

SP - S1-S5

JO - Open Forum Infectious Diseases

JF - Open Forum Infectious Diseases

IS - Supplement_1

ER -

Optimizing Vaccine Trials for Enteric Diseases: The Enterics for Global Health (EFGH) Shigella Surveillance Study

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this